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462 patients presenting with chest pain to a rural district general hospital underwent calcium scoring and pretest clinical risk
assessment in order to stratify subsequent investigations and treatment was retrospectively reviewed. The patients were followed
up for two years and further investigations and outcomes recorded. Of the 206 patients with zero calcium score, 132 patients were
immediately discharged from cardiac follow-up with no further investigation on the basis of their calcium score, low pretest risk
of coronary artery disease, and no significant incidental findings. After further tests, 267 patients were discharged with no further
cardiac therapy, 88 patients were discharged with additional medical therapy, and 19 patients underwent coronary artery by-pass
grafting or percutaneous intervention. 164 patients with incidental findings on the chest CT (computed tomography) accompanying
calcium scoring were reviewed, of which 88 patients underwent further tests and follow-up for noncardiac causes of chest pain.The
correlations between all major risk factors and calcium scores were weak except for a combination of diabetes and hypertension in
the male gender (𝑃 = 0.012), The use of calcium scoring and pretest risk appeared to reduce the number of unnecessary cardiac
investigations in our patients: however, the calcium scoring test produced a high number of incidental findings on the associated
CT scans.
1. Introduction
Coronary artery calcification has been used for a considerable
amount of time as an assessment of risk for coronary
artery disease. In the UK, the coronary calcium score has
been incorporated into guidelines produced by the National
Institute of Clinical Excellence (NICE), which has in turn
developed an algorithm for the use of imaging investigations
into chest pain of recent onset [1]. This guidance was
developed by analysis of the currently available evidence on
the use of imaging in the management of coronary artery
disease. One specific recommendation is that exercise testing
should no longer be used in theUKas ameans of determining
the probability of coronary artery disease.
Coronary calcification has been noted as an incidental
finding on chest computed tomography for some time [2];
however, a large number of studies have demonstrated both
prospectively and retrospectively that coronary calcification
is a sensitive indicator of risk of adverse cardiac events and
this has led to the publication of joint guidelines of the use of
computed tomography in chest pain by the European Society
of Cardiac Radiology and the North American Society for
Cardiac Imaging [3].
More recently there has been the development of guide-
lines on the use of other imagingmodalities which can follow
on from the detection of coronary calcium, such as the use
of single photon emission computed tomography (SPECT)
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in myocardial imaging [4]; these new guidelines have been
reflected in both the updatedNICE guidance and the practice
in most hospitals in the UK. Among the most compelling
data is the value of a zero calcium score which has been
outlined in a number of papers and was also a feature of a
paper written by the European Society of Cardiac Radiology
[5].Whilst the earlywork on calcium scoring concentrated on
the risk of presence of coronary artery disease in symptomatic
patients, there is continuing debate of the value of this test for
screening for coronary artery disease, the value of which is
being increasingly doubted [6].
A question remains as to whether calcium scoring should
be the first line investigation in symptomatic patients or
whether patients should go straight to computed tomo-
graphic coronary angiography (CTCA) or invasive coronary
angiography; the case for using calcium scoring as a first line
investigation has been made in the UK NICE [1] guidance
and supported by many authors [7–9], some of which argue
that using calcium scoring as a first line diagnosis rather than
CTCA may be more cost effective [10]. This approach may
also be very useful in populations where access to CTCA
is limited. Others point to its wide applicability with very
few exclusions [11]. Certainly calcium scoring performed
without CTCA is a quicker technique with a lower radiation
dose [12] and very much quicker than an exercise ECG;
a typical calcium score takes approximately 5 minutes to
perform and be interpreted [13]. Combining calcium scoring
and CTCA results in a higher radiation dose and a longer
examination.The question as to the role of calcium scoring as
the preliminary step of cardiac imaging investigation should
therefore be further explored.
In order to investigate whether the use of calcium scoring
alone as a first line test is helpful in the diagnosis of chest
pain, we undertook a prospective audit of 463 patients
who undertook this test as the primary preliminary test for
coronary artery disease and followed these patients up for a
period of two years.
2. Methods
2.1. Patient Population. All patients assessed were from a
population in North West Wales with a hospital catchment
area of approximately 250,000 patients. All patients with
stable chest pain attending chest pain or associated medical
clinics were entered into the study.
The patient data, which was collected, included age,
gender, cholesterol and lipid levels, and the presence of
hypertension and diabetes. Outcomes measured included
the number of coronary angiograms performed and their
result, the number and type of other tests performed, and
the presence of incidental findings. Patients were followed
up for two years in the cardiology clinic or by rereferral
or representation in the case of patients who had been
discharged.
2.2. Scan and Postprocessing Protocol. Calcium scoring was
carried out on a Symbia T16 Scanner. Following patient
preparation and attachment of ECG leads, the patient was
placed feet first into the scanner in a supine position and
an anteroposterior and lateral topogram was acquired at
25 milliamperes (mA) and 130 kilovolts (kV) with a 5.9-
second scan time, using a 0.6mm slice thickness. The trigger
and scan area for the calcium scoring scan was then set
and the calcium scoring scan carried out with a 0.5-second
rotation time at 37mA and 130 kV with a pitch factor of
0.31 using retrospective ECG triggering. Slice thickness was
set at 2.4mm. All scans were acquired using a Siemens
Caredose protocol giving an average exposure for males of
2.25 millisieverts (mSv) and for females 2.68 (mSv).
The calcium score is then calculated using an Agatston
scoring system by examination of the regions of interest
using a Symbia IQSPECT workstation with a computed
tomography work package using Syngo protocols. Following
this, the chest CT component was examined on a Fuji
patient archiving computer system (PACS) and reported for
incidental findings by experienced radiologists; all incidental
findings on the CT scans were recorded.
A cut-off for themaximumcalcium scorewas determined
to be 1500. All calcium scores above this level were classified
as a calcium score of 1500. Calcium scores above zero but less
than 1 were scored as a calcium score of 1.
Calcium score results were analysed in relation to age,
gender, andpretest probability.The analysis of risk factors and
test results were also stratified according to age and gender.
2.3. Data Analysis. Data was recorded on a Microsoft Excel
worksheet and analysed using SPSS 22 (IBM). Patient gender,
age, pretest, risk and calcium score data was initially explored
using the descriptive statistics package in SPSS to calculate
means and distribution. Pearson correlation coefficients were
calculated for the relationship between the main data vari-
ables. 𝑡-tests and a one-way ANOVA (analysis of variance)
were used to compare variables. Continuous variables were
expressed asmean± standard deviation. Categorical variables
were expressed as percentages.
3. Results
3.1. Patient Population. 462 patients were entered into the
study (age range 29–85, mean 58.7 ± SD 10.5 years); of these
259 were female (age 29–85, mean 59.7 ± SD 10.6 years) and
203 male (age 30–84, mean 57.4 ± SD 10.32 years). Patients
were assessed as having a pretest probability of coronary
disease according to the methodology outlined in NICE
guidance [14]. These levels of risk were then simplified to
three categories of risk: (a) low risk (0–29%), (b)medium risk
(30–60%), or (c) high risk (>60%).
The mean pretest probability for coronary artery disease
for this group was (a) female 36.56 ± SD 27.4 (medium
pretest probability) and (b)male 65.66± SD 26.8 (high pretest
probability).
3.2. Calcium Score (Figures 1, 2, and 3). The distribution of
calcium scores is shown in Figures 1–3. This demonstrates
that a zero calcium score was the commonest finding and that
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Figure 1: Distribution of calcium scores in patients with a low
pretest risk of coronary disease.
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Figure 2: Distribution of calcium scores in patients with a medium
pretest risk of coronary disease.
a zero calcium score may be found in all age groups and all
risk groups.
Themean calcium score was calculated as follows: female
90.94 ± SD 245.6 and male 191.96 ± SD 356.4.
3.3. Relationship between Calcium Score, Diabetes, and Hyper-
tension (Table 1). Analysis of the relationship between dia-
betes, hypertension, and calcium score showed little rela-
tionship between these factors, except between calcium score
and a combination of diabetes and hypertension for the male
gender (𝑃 = 0.012).The other relationships showed either no
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Figure 3: Distribution of calcium scores in patients with a high
pretest risk of coronary disease.
significant difference or very weak relationships.The findings
are summarized in Table 1.
3.4. Relationship between Pretest Risk and Calcium Score
(Table 2). 132 patients had a low pretest risk and a zero
calcium score; the majority of these were female patients
(𝑛 = 114). 72 patients had a zero calcium score and medium
pretest risk (female 𝑛 = 52) and 50 patients had a zero calcium
score and a high pretest risk (female 𝑛 = 29). The results are
summarised in Figures 1, 2, and 3 and Table 2.
The Pearson correlation (𝑟) for pretest probability and
calcium score for gender was 0.322 for male patients and
0.366 for female patients. Both have statistical significance to
the 0.01 level (Table 3).
The overall correlation between pretest probability of
coronary disease and calcium score gave a Pearson correla-
tion (𝑟) of 0.491, which is equivalent to 0.01 level indicating
statistical significance.The correlation between calcium score
and age gave a Pearson correlation of 𝑟 = 0.340, which is also
significant to the 0.01 level with statistical significance.
3.5. Relationship between Coronary Angiogram Findings, Pre-
test Risk, and Calcium Score (Table 3). Coronary angiograms
were performed on 53 male patients and 32 female patients;
the findings are summarized in Table 3.
All the angiograms with moderate or significant findings
had calcium scores above 10. Two patients with significant
coronary artery disease had calcium scores in the range 10–
100. No patients with a zero calcium score had a positive
angiogram; one patient with a calcium score of 6 had a 30%
stenosis in the left anterior descending coronary artery, and
this patient had a high pretest probability.Thirty patients with
a calcium score above 400 had positive angiograms with only
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Table 1: The relationship between calcium scores and diabetes and hypertension.
Sex Diabetes Hypertension 𝑁 Mean Std. deviation Std. error mean
Female
No No Calcium score 𝑃 = NS 157 80.661 243.6941 19.4489
Yes Calcium score 𝑃 = NS 70 117.361 238.9071 28.5549
Yes No Calcium score 𝑃 = .043 17 33.024 61.9628 15.0282
Yes Calcium score 𝑃 = .185 15 140.933 391.3516 101.0465
Male
No No Calcium score 𝑃 = NS 112 127.568 244.7537 23.1271
Yes Calcium score 𝑃 = NS 64 251.000 424.6471 53.0809
Yes No Calcium score 𝑃 = .154 5 412.720 526.3036 235.3701
Yes Calcium score 𝑃 = .012 22 297.895 505.1356 107.6953
This table shows the distribution of calcium score in the study population and the relationship to diabetes and hypertension, twomajor risk factors for coronary
disease. The relationship between calcium score and these risk factors is weak. It is strongest for the male gender and diabetes combined with hypertension.
Table 2: Calcium score versus pretest risk.
Calcium score No = lowpretest risk
𝑁 = medium
pretest risk
𝑁 = high
pretest risk
Zero calcium score,
male 18 20 21
Zero calcium score,
female 114 52 29
Calcium score
1–400, male 11 24 76
Calcium score
1–400, female 15 15 17
Calcium score
>400, male 1 2 30
Calcium score
>400, female 3 5 9
This table shows the numbers of patients with a particular calcium score
range and their pretest risk, which is classified as low, medium, or high. The
majority of patients with a zero calcium score have a low pretest risk, but
significant numbers of patients have a zero calcium score with a high pretest
risk.
5 patients with a calcium score above 400 having negative
angiograms.
3.6. Relationship between Cholesterol and HDL Levels and
CalciumScore. Therewas no significant relationship between
calcium score and cholesterol level.
3.7. Relationship between Calcium Score and Follow-Up Car-
diac Investigations. 71 female patients underwent exercise
tests of which 37 were inconclusive (mean calcium score
52.86) and 32 negative (mean calcium score 35.5); one test
was positive (calcium score 38).This patient had a subsequent
normal coronary angiogram. A further test precipitated a
broad complex tachycardia (calcium score 0). Sixty-six male
patients had exercise tests of which 35 were negative (mean
calcium score 68.8) and 31 inconclusive (mean calcium score
192.2). One patient with a negative exercise test hadmoderate
coronary artery disease on angiography, while 2 patients
with inconclusive exercise tests hadmoderate coronary artery
disease on angiography; 4 patients with inconclusive tests had
normal coronary angiograms.
Seven female patients had myocardial perfusion scans
(MPI), all of which were negative. Four male patients under-
went MPI scans, all of which were negative.
3.8. Incidental Findings and Resulting in Further Follow-Up
Investigations. 134 patients with a zero calcium score had no
incidental findings on their computed tomography scans; 65
patients with a zero calcium score had incidental findings on
computed tomography.
In total 155 patients (87 female) had incidental findings
on the computed tomography scans; most of these were
considered nonsignificant requiring no further action. The
more significant findings included 18 patients with lung
nodules or lymph nodes, requiring further assessment, 7
patients with ground glass pulmonary shadowing, and 9
patients with significant pleural-based abnormalities includ-
ing 2 patients with pleural effusion and two patients with
calcified plaques and one patient with a pleural-based mass.
16 patients had a hiatus hernia, which may have contributed
to their symptoms.One patient had possible tuberculosis; one
patient had a possible liver metastasis, which was found to be
a simple cyst on follow-up. Further 6 patients were found to
have liver cysts.
3.9. Patient Outcomes (Table 4). Of the 267 patients whowere
discharged from follow-up cardiac care at the hospital with no
further cardiac treatment, 132 patients were discharged on the
basis of having a zero calcium score and low pretest probabil-
ity.The remaining 135 were discharged from cardiac care after
negative subsequent tests and follow-up consultation with no
change in therapy.
Of the remaining 195 patients, 88 were given further
medical treatment and advice, which included primary and
secondary prevention. 19 patients underwent revascularisa-
tion by either percutaneous coronary angioplasty or coronary
by-pass grafting, the revascularisation group representing
4.1% of the total patients number. The remaining 88 patients
are undergoing additional tests and follow-up which include
investigation of incidental findings on the chest CT, which
formed part of the calcium scoring investigation. Other
cardiac syndromes, which were diagnosed in follow-up,
included paroxysmal atrial fibrillation, hypertrophic car-
diomyopathy, and aortic stenosis.
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Table 3: Angiogram severity versus pretest risk.
Pretest Risk Normal angiogram %
Plaque but no
significant stenosis
(mild) %
Moderate soft plaque
stenosis, less than 60%
(moderate) %
Severe obstructive
disease (severe) %
Low, male 0% 7% 0% 0%
Low, female 2% 3% 0% 0%
Medium, male 0% 0% 0% 0%
Medium, female 0% 2% 0% 5%
High, male 13% 10% 7% 25%
High, female 10% 5% 8% 3%
Total 25% 27% 15% 33%
Table showing that 25% of the angiograms performed were normal and 27% showed nonsignificant plaque. 28% of significantly abnormal angiograms had a
high pretest risk of coronary disease, but in the high-risk group there were also 23% of normal angiograms. No patient with a low pretest risk had a significantly
abnormal angiogram.
Table 4: Patient outcomes versus calcium score.
Discharge Medical Rx CABG PCI Other investigations/outcomes
Zero calcium score, male, 𝑛 = 59 50 4 0 0 5
Zero calcium score, female, 𝑛 = 195 156 15 0 0 24
Calcium score 1–400, male, 𝑛 = 111 45 20 1 5 40
Calcium score 1–400, female, 𝑛 = 47 12 17 2 2 14
Calcium score >400, male, 𝑛 = 33 3 20 3 4 3
Calcium score >400, female, 𝑛 = 17 1 12 1 1 2
Total 267 88 7 12 88
Table demonstrating the outcomes of the patient group in relation to their calcium score. The majority of patients with a zero calcium score were discharged
unless they had a high pretest risk of coronary disease. No patient with a zero calcium score required revascularization.
Four patients with zero calcium scores presented again
with chest pain but no evidence of troponin rise. After
subsequent investigations, no evidence of coronary disease
was found. Five patients with significantly raised calcium
scores experienced an acute cardiac event, and one of these
was fatal.
4. Discussion
There are still centres that do not have access to high quality,
high speed cardiac computed tomographic imaging. It is
generally accepted that a minimum specification of 64-slice
CT is required for good cardiac diagnosis of coronary artery
disease [1]. Some centres will still have only 4- or 16-slice CT
available, which can perform calcium scoring but not CTCA.
Even when CTCA is available, a strategy for using calcium
scoring as the initial investigationmay be more effective than
routine use of CTCA as the first line investigation.
All the patients in this study were symptomatic but with
stable symptoms and presented either to chest pain or other
cardiac clinics. Of the 462 patients investigated, 132 patients
could be immediately reassured that their combined risk
assessment and calcium score meant that they could be dis-
charged without further cardiac investigation or treatment;
however, some of these patients required further follow-up
for incidental findings on their CT scans.
Current guidance suggests [1] that patients with a calcium
score of above 1 and below 400 should have CTCA and that
patients with calcium scores above 400 should be considered
either for a stress imaging test if the risk assessment is mod-
erate, but if the risk assessment is high, they should undergo
angiography. In our patient group, 157 patients would have
been suitable under UK guidelines to have CTCA were
this available. In this group of patients, only 10 underwent
coronary intervention or surgery after coronary angiography.
It could be argued therefore that had CTCA been used
in this group, approximately 25% of the invasive coronary
angiography examinations which were subsequently proved
to be normal could have been avoided. We also performed
calcium score examinations on 172 patients with high pretest
risk; of these patients, 50 had a zero calcium score, indicating
that pretest risk by itself may not effectively stratify patients
with chest pain.
The combination of assessment of pretest risk and the
use of calcium score is arguably a very strong rationale
for the determination of subsequent cardiac investigation in
patients with stable chest pain. Patients with a combination
of zero calcium scores and low pretest risk should not require
further cardiac investigations or treatment for coronary
artery disease. Our study shows a moderately strong level of
correlation between these two assessments (𝑃 = 0.01).
Previous large studies have shown the importance of
the relationship between CTCA and pretest probability
(CORE-64 Study) [15] in the investigation of patients with
chest pain rather than relying on CTCA alone. This latter
study also demonstrated that high calcium in the coronary
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artery reduced the accuracy of CTCA which indicates that
a CTCA strategy alone may be inaccurate in these patients.
A recent study on patients with zero calcium scores using
positron emission tomography has shown that 16%of patients
with a zero calcium score have inducible ischaemia [16].
In our series, no patients with a zero calcium score had
positive angiography and only one patient with a low calcium
score had a positive angiogram demonstrating a moderate
lesion (30% left anterior descending coronary artery); this
patient had a high pretest probability of coronary disease.
Many studies have shown that significant coronary stenoses
can occur in patients with low calcium scores [17], whilst
some studies found positive angiograms in patients with zero
calcium scores [18]. One such study was a subset of the CORE
64 study consisting of 71 patients with a zero calcium score
who were examined and found to have a 12.5% requirement
for revascularisation [19]. This finding together with our
study would argue against the use of calcium scoring as the
sole determinant of further investigation. Pretest probability
is an established method of determining the risk of coronary
artery disease [20] and has been used in most trials of
noninvasive imaging for coronary artery disease [21]. It has
been proposed that not only should pretest probability not
be discarded in favour of using calcium scoring but the
combination of the twomethods is amore powerful predictor
of the need for further investigation and treatment. The
CORE 64 study also concluded that both calcium scoring
and pretest probability were important for the effectiveness
of CTA to confirm or exclude the presence of obstructive
coronary artery disease.
It is of interest to note that our study showed either
weak or nonsignificant relationships between various risk
factors and calcium score.There was no relationship between
cholesterol or lipid levels and calcium scoring. The strongest
relationship was between a combination of diabetes and
calcium scoring for the male gender and a lesser relationship
between diabetes and the female gender.
Our study also demonstrated that when the whole of
the CT examination was examined, numerous other findings
were found. The adjunct CT was reported by an experienced
radiologist in all cases and a very large number of these
“incidental” findings were recorded. Most of these findings
were judged to be benign and of no significant clinical
consequence; however, a large number of findings were
reported which indicated other possible causes for chest
pain, such as infection, pleurisy, and hiatus hernia. Incidental
CT findings on CTCA have been investigated previously
with one large series reporting that 56% of patients had
reportable incidental findings [22].There is continued debate
over whether these findings should be reported or followed
up [23]. In our study, there appeared to be clear benefits from
reporting and following up these incidental findings in terms
of discovery of alternative explanations for chest pain and
treating them.
This study was a retrospective single arm audit, which
entered all patients with stable chest pain into a calcium
scoring protocol. The limitations of the study are that (a) we
could not compare calcium scoring with CTCA to calcium
scoring alone and that (b) we made an assumption that
patients with a zero calcium score and low pretest probability
required no further cardiac investigations unless they had a
recurrence of chest pain.
5. Conclusions
The study demonstrates the utility of calcium scoring as a
sole CT examination in patients presenting with chest pain.
Combined with pretest probability using a standard risk
table, all cases of moderate and significant coronary disease
demonstrated on subsequent angiography were excluded. A
significant number of patients could therefore be reassured
and discharged from further investigations based on these
two measures. Calcium scoring alone may lead to missing
some soft plaque lesions, which may be of significance. This
methodology appears to reduce the need for subsequent
investigations but does not eliminate it. The study also
demonstrated that examination of the associated CT scans
did reveal a number of noncardiac findings, which may have
either caused or contributed to chest symptoms.
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